- 全部删除
您的购物车当前为空
FHD-286 是 BRM/BRG1 ATPase 的抑制剂,可用于治疗 BAF 相关疾病如急性髓性白血病的研究。


为众多的药物研发团队赋能,
让新药发现更简单!
FHD-286 是 BRM/BRG1 ATPase 的抑制剂,可用于治疗 BAF 相关疾病如急性髓性白血病的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,480 | In stock | |
| 5 mg | ¥ 2,970 | In stock | |
| 10 mg | ¥ 4,480 | In stock | |
| 25 mg | ¥ 6,780 | In stock | |
| 50 mg | ¥ 9,170 | In stock | |
| 100 mg | ¥ 12,300 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 3,790 | In stock |
FHD-286 相关产品
| 产品描述 | FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia. |
| 分子量 | 562.66 |
| 分子式 | C24H30N6O6S2 |
| CAS No. | 2671128-05-3 |
| Smiles | COC[C@H](NC(=O)c1ccn(c1)S(C)(=O)=O)C(=O)Nc1nc(cs1)-c1cccc(n1)N1C[C@H](C)O[C@H](C)C1 |
| 密度 | 1.46 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 245 mg/mL (435.43 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容